beta-lactams has been researched along with Peritonitis in 40 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (5.00) | 18.7374 |
| 1990's | 2 (5.00) | 18.2507 |
| 2000's | 20 (50.00) | 29.6817 |
| 2010's | 14 (35.00) | 24.3611 |
| 2020's | 2 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JHK; Davies, J; Gao, P; Halebeedu Prakash, P; Ho, PL; Iu, HTV; Kao, RYT; Li, Y; Tai, SSC; Wan, RE; Wei, Y; Wong, KW; Yam, HCB; Yuen, KY | 1 |
| Birckener, J; Butin-Druoton, AL; Germain, A; Guerci, P; Leon, L; Losser, MR; Luc, A; Novy, E; Pape, E; Scala-Bertola, J; Thilly, N | 1 |
| Bajaksouzian, S; Barnes, MD; Bethel, CR; Bhagwat, SS; Bhavsar, S; Bonomo, RA; Deshpande, PK; Jacobs, MR; Kumar, V; Nguyen, NQ; Papp-Wallace, KM; Patel, MV; Patil, V; Rather, PN; Ravikumar, T; Rudin, SD; van den Akker, F; Yeole, R | 1 |
| Amaduzzi, A; Ansaloni, L; Baiocchi, GL; Catena, F; Coccolini, F; Cucchi, M; Di Saverio, S; Lazzareschi, D; Pasqualini, E; Pinna, AD; Sartelli, M; Schiavina, R; Vallicelli, C | 1 |
| Bandettini, R; Buffa, P; Castagnola, E; Caviglia, I; Ciucci, A; Ginocchio, F; Guida, E; Haupt, R; Loy, A; Masa, DL; Mattioli, G; Perotti, M; Pini Prato, A | 1 |
| Belghiti, J; Bert, F; Dondero, F; Durand, F; Larroque, B; Moreau, R; Nicolas-Chanoine, MH; Paugam-Burtz, C | 1 |
| Cachero, A; Castellote, J; Dueñas, E; Girbau, A; Grau, I | 1 |
| Chang, M; Janardhanan, J; Mobashery, S | 1 |
| Evans, D; Horn, P; Lee, P; Marsh, A; Slepavicius, A; Solomkin, J; Sutcliffe, JA; Tsai, L | 1 |
| Fernández, L; Gómez-Rice, A; Lillo, M; Maseda, E; Ramasco, F; Villagrán, MJ | 1 |
| Dibirov, MD; Fesenko, TA; Karsot'ian, GS; Khachatrian, NN; Poliakov, IA | 1 |
| García, E; García, FJ; García, JE; García, MB; García, MI; González, B; Lozano, FS | 1 |
| Badal, RE; Bouchillon, SK; Hawser, SP; Hoban, DJ | 1 |
| Boutbaoucht, M; Laghla, B; Nejmi, H; Samkaoui, MA | 1 |
| Ansaloni, L; Catena, F; Coccolini, F; Di Saverio, S; Ercolani, G; Gazzotti, F; Lazzareschi, D; Pinna, AD | 1 |
| Cady, A; Le Touvet, B; Mallédant, Y; Seguin, P; Tribut, O; Verdier, MC | 1 |
| Bereznitskiĭ, IaS; Bezdetko, NV | 1 |
| Couet, W; Grégoire, N; Marliat, M; Mimoz, O; Nordmann, P; Poirel, L | 1 |
| Chen, CC; Cheng, KC; Chiang, SR; Chiu, YH; Chuang, YC; Ko, WC; Ku, YH; Tang, HJ; Zhang, CC | 1 |
| Carides, A; Choe, KA; Christou, NV; Dellinger, EP; Fernandez, A; Malafaia, O; Rotstein, OD; Satishchandran, V; Solomkin, JS; Tellado, JM; Teppler, H; Yellin, AE | 1 |
| Zaĭtsev, AA | 1 |
| Ariza, J; Cabellos, C; Domenech, A; Domínguez, MA; Gudiol, F; Liñares, J; Montero, A; Ribes, S | 1 |
| Ariza, J; Cabellos, C; Domenech, A; Domínguez, MA; Gudiol, F; Liñares, J; Montero, A; Ribes, S; Taberner, F; Tubau, F | 1 |
| Kotapati, S; Kuti, JL; Nicolau, DP | 1 |
| Asperger, W; Chan, CY; Dela Pena, AS; DiNubile, MJ; Giezek, H; Kafka, R; Köckerling, F; Raz, R; Shivaprakash, M; Vrijens, F; Warren, B | 1 |
| Barra, D; Bozzi, A; Cirioni, O; Di Giulio, A; Ghiselli, R; Giacometti, A; Luzi, C; Mangoni, ML; Mocchegiani, F; Orlando, F; Rinaldi, AC; Saba, V; Scalise, G; Silvestri, C | 1 |
| Burkhardt, O; Derendorf, H; Welte, T | 1 |
| Shinagawa, N; Takeyama, H; Taniguchi, M; Yura, J | 1 |
| Chatterjee, I; Iredell, JR; Lipman, J; Woods, M | 1 |
| Abramson, MA; Jensen, EH; Namias, N; Solomkin, JS; Tomassini, JE | 1 |
| Del Prado, G; García, E; García, P; Gracia, M; Huelves, L; López, R; Ponte, C; Rodríguez-Cerrato, V; Soriano, F | 1 |
| Aubert, D; Mazoit, JX; Nordmann, P; Poirel, L; Vimont, S | 1 |
| Basoli, A; Chirletti, P; Cirino, E; D'Ovidio, NG; Doglietto, GB; Ecari, M; Giglio, D; Giulini, SM; Malizia, A; Petrovic, J; Taffurelli, M | 1 |
| Mikamo, H; Shinagawa, N; Takesue, Y; Takeyama, H; Tanaka, K; Taniguchi, M; Watanabe, K; Yokoyama, T | 1 |
| Mazzei, T; Novelli, A | 1 |
| Akalin, HE | 1 |
| Berry, V; Mizen, L; Woodnutt, G | 1 |
| Pechère, JC | 1 |
| Bryan, LE; Godfrey, AJ; Schollardt, T | 1 |
5 review(s) available for beta-lactams and Peritonitis
| Article | Year |
|---|---|
The oxadiazole antibacterials.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Female; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Oxadiazoles; Peritonitis; Quantitative Structure-Activity Relationship; Staphylococcal Infections; Vancomycin-Resistant Enterococci | 2016 |
Ertapenem: the new carbapenem 5 years after first FDA licensing for clinical practice.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Clinical Trials as Topic; Community-Acquired Infections; Critical Illness; Drug Interactions; Drug Resistance, Bacterial; Endometritis; Ertapenem; Female; Humans; Peritonitis; Protein Binding; Renal Insufficiency; Surgical Wound Infection; Urinary Tract Infections | 2007 |
The implications of enterococci for the intensive care unit.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Clindamycin; Cross Infection; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Infection Control; Intensive Care Units; Peritonitis; Risk Factors; Vancomycin | 2007 |
[Pharmacological rationale for choice of antibiotics for intraabdominal infections].
Topics: Abdominal Abscess; Acetamides; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Digestive System Diseases; Drug Therapy, Combination; Fluoroquinolones; Humans; Linezolid; Metronidazole; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Peritonitis; Sepsis; Tigecycline; Treatment Outcome; Virginiamycin | 2008 |
The role of beta-lactam/beta-lactamase inhibitors in the management of mixed infections.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Brain Abscess; Diabetic Foot; Drug Therapy, Combination; Endometritis; Enzyme Inhibitors; Female; Humans; Peritonitis; Surgical Wound Infection | 1999 |
10 trial(s) available for beta-lactams and Peritonitis
| Article | Year |
|---|---|
T.E.A. Study: three-day ertapenem versus three-day Ampicillin-Sulbactam.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactams; Chi-Square Distribution; Drug Administration Schedule; Ertapenem; Female; Humans; Male; Middle Aged; Peritonitis; Sulbactam; Surgical Wound Infection; Treatment Outcome | 2013 |
Assessing the Efficacy and Safety of Eravacycline vs Ertapenem in Complicated Intra-abdominal Infections in the Investigating Gram-Negative Infections Treated With Eravacycline (IGNITE 1) Trial: A Randomized Clinical Trial.
Topics: Abdominal Abscess; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Appendicitis; Bacterial Infections; beta-Lactams; Double-Blind Method; Ertapenem; Female; Gram-Negative Bacteria; Humans; Intention to Treat Analysis; Male; Middle Aged; Peritonitis; Tetracyclines; Treatment Outcome; Young Adult | 2017 |
[Septic shock due to community-acquired complicated intra-abdominal infection treated with ertapenem: outcome in 25 cases].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cohort Studies; Community-Acquired Infections; Critical Care; Emergencies; Ertapenem; Female; Hospital Mortality; Humans; Intestinal Perforation; Length of Stay; Male; Middle Aged; Peritonitis; Prospective Studies; Shock, Septic; Survival Analysis; Treatment Outcome | 2008 |
A prospective, multi centre, randomized clinical study to compare the efficacy and safety of Ertapenem 3 days versus Ampicillin-Sulbactam 3 days in the treatment of localized community acquired intra-abdominal infection. (T.E.A. Study: Three days Ertapene
Topics: Abdomen; Adult; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Clinical Protocols; Community-Acquired Infections; Drug Therapy, Combination; Ertapenem; Humans; Peritonitis; Sulbactam | 2011 |
Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial.
Topics: Abdominal Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Digestive System Surgical Procedures; Double-Blind Method; Drug Therapy, Combination; Ertapenem; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hospitalization; Humans; Lactams; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Research Design; Treatment Outcome | 2003 |
[Carbapenem antibiotic ertapenem in the treatment of extrahospital intraabdominal infections].
Topics: Abdominal Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Double-Blind Method; Ertapenem; Female; Humans; Lactams; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Prospective Studies; Tazobactam; Treatment Outcome | 2003 |
[Efficacy of invanz proven in the treatment of intra-abdominal infections in one of the largest studies yet conducted on surgical patients].
Topics: beta-Lactams; Ertapenem; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Lactams; Peritonitis; Postoperative Complications; Treatment Outcome | 2003 |
Efficacy and safety of ertapenem versus piperacillin-tazobactam for the treatment of intra-abdominal infections requiring surgical intervention.
Topics: Abdomen; Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Anti-Bacterial Agents; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; beta-Lactams; Diarrhea; Ertapenem; Escherichia coli Infections; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Treatment Outcome | 2006 |
Randomized, multicenter, double-blind study of efficacy, safety, and tolerability of intravenous ertapenem versus piperacillin/tazobactam in treatment of complicated intra-abdominal infections in hospitalized adults.
Topics: Abdominal Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Bacterial Infections; Bacteroides; beta-Lactams; Double-Blind Method; Ertapenem; Escherichia coli; Female; Humans; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2007 |
A prospective, double-blind, multicenter, randomized trial comparing ertapenem 3 vs >or=5 days in community-acquired intraabdominal infection.
Topics: Anti-Bacterial Agents; APACHE; Appendicitis; beta-Lactams; Community-Acquired Infections; Double-Blind Method; Ertapenem; Humans; Peritonitis; Prospective Studies; Surgical Wound Infection | 2008 |
25 other study(ies) available for beta-lactams and Peritonitis
| Article | Year |
|---|---|
Subinhibitory Concentrations of Antibiotics Exacerbate Staphylococcal Infection by Inducing Bacterial Virulence.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Peritonitis; Reproducibility of Results; Staphylococcal Infections; Tetracycline; Virulence Factors | 2022 |
Serum and peritoneal exudate concentrations after high doses of β-lactams in critically ill patients with severe intra-abdominal infections: an observational prospective study.
Topics: Aged; Ascitic Fluid; beta-Lactams; Critical Illness; Cross Infection; Dose-Response Relationship, Drug; Female; France; Humans; Intraabdominal Infections; Male; Middle Aged; Peritonitis; Prospective Studies | 2020 |
Strategic Approaches to Overcome Resistance against Gram-Negative Pathogens Using β-Lactamase Inhibitors and β-Lactam Enhancers: Activity of Three Novel Diazabicyclooctanes WCK 5153, Zidebactam (WCK 5107), and WCK 4234.
Topics: Animals; Azabicyclo Compounds; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Bridged Bicyclo Compounds; Cyclooctanes; Drug Synergism; Gram-Negative Bacteria; Lung; Mice; Octanes; Peritonitis; Piperidines | 2018 |
Susceptibility to antibiotics of aerobic bacteria isolated from community acquired secondary peritonitis in children: therapeutic guidelines might not always fit with and everyday experience.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Child; Community-Acquired Infections; Drug Resistance, Bacterial; Drug Therapy, Combination; Ertapenem; Gentamicins; Hospitals, Pediatric; Humans; Italy; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Practice Guidelines as Topic; Sulbactam; Thienamycins | 2013 |
Risk factors associated with preoperative fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in liver transplant recipients.
Topics: Adult; Amikacin; beta-Lactamases; beta-Lactams; Cefoxitin; Ciprofloxacin; Drug Resistance, Bacterial; End Stage Liver Disease; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Feces; Female; Humans; Imipenem; Klebsiella; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Preoperative Period; Risk Factors; Severity of Illness Index | 2014 |
Ertapenem failure as therapy for nosocomial spontaneous bacterial peritonitis.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Substitution; Ertapenem; Escherichia coli; Escherichia coli Infections; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hepatorenal Syndrome; Humans; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Male; Middle Aged; Peritonitis; Postoperative Complications; Treatment Failure | 2016 |
[Ertapenem in combined therapy for generalized peritonitis].
Topics: Anti-Bacterial Agents; beta-Lactams; Combined Modality Therapy; Ertapenem; Humans; Peritonitis | 2008 |
[Activity of Ertapenem and Ceftriaxone in the eradication of Salmonella in a model of experimental peritonitis in mice].
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Dose-Response Relationship, Drug; Ertapenem; Male; Mice; Peritonitis; Salmonella enterica; Salmonella Infections | 2009 |
Epidemiologic trends, occurrence of extended-spectrum beta-lactamase production, and performance of ertapenem and comparators in patients with intra-abdominal infections: analysis of global trend data from 2002-2007 from the SMART study.
Topics: Africa; Animals; Anti-Bacterial Agents; Asia; Australasia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Ertapenem; Europe; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Latin America; Middle East; North America; Peritonitis | 2010 |
[Evolution of Escherichia coli resistance in community acquired peritonitis].
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Appendicitis; beta-Lactams; Cephalosporins; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Intestines; Male; Morocco; Peptic Ulcer Perforation; Peritonitis; Practice Guidelines as Topic; Prospective Studies | 2011 |
Ertapenem in plasma and peritoneal fluid from patients with severe intra-abdominal infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ascitic Fluid; beta-Lactams; Ertapenem; Female; Humans; Intensive Care Units; Male; Middle Aged; Peritonitis; Plasma | 2011 |
[Clinical-economic analysis of antibacterial therapy of acute peritonitis].
Topics: Acute Disease; Anti-Bacterial Agents; beta-Lactams; Clinical Trials as Topic; Cost-Benefit Analysis; Decision Trees; Drug Therapy, Combination; Ertapenem; Health Care Costs; Humans; Models, Theoretical; Peritonitis; Treatment Outcome | 2011 |
Broad-spectrum β-lactam antibiotics for treating experimental peritonitis in mice due to Klebsiella pneumoniae producing the carbapenemase OXA-48.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cefotaxime; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Ertapenem; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Lethal Dose 50; Mice; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Plasmids; Survival Rate | 2012 |
Use of Carbapenems against clinical, nontyphoid Salmonella isolates: results from in vitro and in vivo animal studies.
Topics: Animals; beta-Lactams; Carbapenems; Cell Line; Doripenem; Ertapenem; Female; Imipenem; Meropenem; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Peritonitis; Salmonella; Thienamycins | 2012 |
A mouse peritonitis model for the study of glycopeptide efficacy in GISA infections.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Glycopeptides; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Peritonitis; Staphylococcal Infections; Staphylococcus aureus | 2004 |
Experimental study on the efficacy of combinations of glycopeptides and beta-lactams against Staphylococcus aureus with reduced susceptibility to glycopeptides.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Glycopeptides; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Peritonitis; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 2005 |
Pharmacodynamic modeling of beta-lactam antibiotics for the empiric treatment of secondary peritonitis: a report from the OPTAMA program.
Topics: Anti-Bacterial Agents; beta-Lactams; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 2005 |
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria.
Topics: Animals; Anti-Infective Agents; Antimicrobial Cationic Peptides; beta-Lactams; Disease Models, Animal; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Lipopolysaccharides; Male; Microbial Sensitivity Tests; Peritonitis; Piperacillin; Proteins; Rats; Rats, Wistar; Shock, Septic | 2006 |
[Bilophila wadsworthia isolated from surgical specimens].
Topics: Anti-Bacterial Agents; beta-Lactams; Bilophila; Ciprofloxacin; Clindamycin; Digestive System Surgical Procedures; Drug Resistance, Bacterial; Humans; Japan; Levofloxacin; Minocycline; Ofloxacin; Peritonitis; Postoperative Complications; Specimen Handling; Surgical Wound Infection | 2006 |
Pneumococcal LytA autolysin, a potent therapeutic agent in experimental peritonitis-sepsis caused by highly beta-lactam-resistant Streptococcus pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Ascitic Fluid; Bacteriophages; beta-Lactams; Colony Count, Microbial; Drug Resistance, Bacterial; Injections, Intraperitoneal; Injections, Intravenous; Mice; Microbial Sensitivity Tests; Muramidase; N-Acetylmuramoyl-L-alanine Amidase; Peritonitis; Pneumococcal Infections; Streptococcus pneumoniae | 2007 |
Broad-spectrum beta-lactams for treating experimental peritonitis in mice due to Escherichia coli producing plasmid-encoded cephalosporinases.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Cephalosporinase; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Mice; Microbial Sensitivity Tests; Peritonitis; Plasmids | 2007 |
[Bacteria isolated from perforation peritonitis and their antimicrobial susceptibilities].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Intestinal Perforation; Male; Middle Aged; Peritonitis | 2007 |
Simulation of human serum pharmacokinetics of cefazolin, piperacillin, and BRL 42715 in rats and efficacy against experimental intraperitoneal infections.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Biological Availability; Cefazolin; Drug Therapy, Combination; Escherichia coli Infections; Humans; Infusions, Intravenous; Lactams; Male; Microbial Sensitivity Tests; Peritonitis; Piperacillin; Rats; Rats, Inbred Strains; Serratia Infections | 1992 |
Emergence of resistance during beta-lactam therapy of gram-negative infections. Bacterial mechanisms and medical responses.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carrier Proteins; Cell Membrane Permeability; Disease Models, Animal; Drug Resistance, Microbial; Enzyme Induction; Gram-Negative Bacteria; Hexosyltransferases; Mice; Mice, Inbred ICR; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; Peritonitis | 1988 |
Virulence of Pseudomonas aeruginosa strains with mechanisms of microbial persistence for beta-lactam and aminoglycoside antibiotics in a mouse infection model.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Microbial; Iron-Dextran Complex; Lethal Dose 50; Mice; Mutation; Peritonitis; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Virulence | 1985 |